Michael L. Keech, M.B.A. New Head of Business Strategy at Lachman Consultant Services, Inc.

We are pleased to announce that Michael Keech will join Lachman Consultants as Head of Business Strategy, effective January 3, 2017.

Mr. Keech comes to Lachman Consultants as a seasoned Quality, Compliance and Manufacturing professional who has worked in the Life Sciences field for over 25 years. Mr. Keech has helped global corporations transform into world-class organizations by providing strategic and tactical guidance on regulatory requirements and compliant solutions involving the clinical and commercial manufacture/control for pharmaceutical, biopharma and medical device companies.

He has held senior level positions that include Vice President and Regulatory, Quality and Compliance Leader at Quintiles Advisory Services; Global Managing Director at Maetrics; Senior Vice President and Global Life Sciences Sector Leader at Celerant Consulting; Executive Director, Advisory Services – Supply Chain and Operations at Ernst & Young; and Director, Life Science Advisory Services at PriceWaterhouseCoopers. He also worked in Senior positions at firms including OSI Pharmaceuticals, Wyeth, and Deloitte Consulting.

Mr. Keech was awarded an M.B.A., Marketing and Logistics degree from the University of Tennessee.

On behalf of Lachman Consultants, we welcome Michael and wish him a long and successful career with Lachman Consultants.

For more than 30 years, Lachman Consultants has been the leader in providing cost-effective consultation and remediation services to the worldwide pharmaceutical, biotechnology, biologic, medical device, diagnostic and dietary supplement industries. With its strong and extensive cadre of consultant specialists and an unparalleled management team, its Compliance, Science & Technology, and Regulatory Practices provide the most expert counsel and array of services available. Lachman Consultants is proud of its tradition of supporting industry efforts to develop and ensure safe, effective and high-quality medical products. It remains committed to helping the industry anticipate and address its challenges through the development and implementation of practical, sustainable and cost-effective solutions based on the integration of scientific principles, evolving regulatory expectations, and technology.